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include comorbid conditions,1,4 cognitive or sen
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symptoms as asthma.
The emphasis in published reports about asthma
the misdiagn sis of asthma, e pecially in older peo
is also some recognition that asthma may be unde
older people,4 and that many people with moderS20 MJA • Volume 183 NuABSTRACT
What we need to know
• Are older people with respiratory symptoms aware this could 
be asthma?
• Which explanations for undiagnosed asthma apply most 
commonly in older Australians with asthma?
• Can we improve awareness of asthma in older people with 
undiagnosed asthma?
• Is the possibility of asthma in older people firmly established 
on the general practitioners’ radar screen?
• What reasons most often determine whether GPs perform 
spirometry in their practice?
What we need to do
• Conduct a representative population study to assess whether 
older Australians recognise respiratory symptoms as being 
asthma and are reporting these symptoms.
• Conduct and evaluate a pilot asthma health promotion 
program for older people.
• Conduct a controlled therapeutic trial of people with 
undiagnosed asthma to assess treatment benefits and 
produce treatment recommendations.
• Identify whether the prominence of asthma in older people 
can be brought to the attention of GPs.
• Analyse more carefully the issues associated with innovation 
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oldA ma is common in older people; they may have hadhma as children, or it may first occur when they areer.1Asthma in older people may be associated with
severe symptoms and chronic airway obstruction,2 resulting in
significant functional limitations. Furthermore, older people
with asthma have higher death rates than their peers.2 However,
diagnosis of asthma in older people is not easy, and misdiagnosis
can occur.3 Factors making the diagnosis more difficult may
sory impair-
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persistent asthma symptoms may be missing out on the benefits
of effective treatment.4
We used the Northwest Adelaide Health (Cohort) Study
(NWAHS) to identify the prevalence and characteristics of
undiagnosed asthma in a representative population sample of
older people.
METHODS
Households in the north-west region of Adelaide were selected at
random from the Electronic White Pages telephone directory and
contacted using computer-assisted telephone interview methods.
Within each household a person was selected at random and up
to five call-backs were made to recruit the person selected. A
sample response rate of 62% was obtained for both the telephone
interview and the clinical study, resulting in a study group of
4060 people.
The telephone interviewers enquired whether respondents
had ever had asthma, whether the asthma had been diagnosed
by a doctor, and whether they currently had asthma. A positive
response to all three questions confirmed self-reported doctor-
diagnosed asthma. In addition, respondents were asked about
health service use (hospital emergency visits and general
practitioner visits); smoking status (current and ex-smoker);
exercise (150 minutes or more of walking or other moderate or
vigorous activity each week); the person’s demographic charac-
teristics (place of birth, highest education level, household
income); and their health-related quality of life (assessed using
the SF-36 health-related quality-of-life questionnaire). The
Selim index for severity of chronic lung disease symptoms7 was
also administered.
After interview, respondents were recruited to one of two area
clinics for medical assessment of health status. This included
spirometry, and measurement of height and weight, which was
converted to body mass index (weight in kilograms divided by
height in metres squared). A person with a body mass index equal
to or greater than 30 kg/m2 was considered to be obese. All clinic
participants were assessed as having asthma if their asthma was
clinically reversible according to European Respiratory Society
criteria,8 or they reported doctor-diagnosed current asthma. This
group was then classified according to whether or not their asthma
had been previously diagnosed by a doctor into “previously
diagnosed” or “undiagnosed”.
Statistical analyses
Data were analysed using the Statistical Package for the Social
Sciences, version 11 (SPSS Inc, Chicago, Ill, USA) and Epi Info 6
(Centers for Disease Control, Atlanta, Ga, USA). Mean quality-of-
life scores were calculated for the physical components summary
of the SF-36 health-related quality-of-life questionnaire. Stand-
ard SF-36 quality-of-life scores were also calculated by the
method of Garrat et al9 for both the physical components
summary and the mental components summary to producember 1 • 4 July 2005
EPIDEMIOLOGY — ASTHMA SUPPLEMENTstandard scores. The mean values for the physical and mental
components summary for the north-west Adelaide population
were set at zero to allow comparisons with the population mean
of the physical and mental health quality-of-life scores for
subjects with “previously diagnosed” and “undiagnosed” asthma.
Univariate descriptive statistical methods were used to examine
the differences between groups with previously diagnosed and
undiagnosed asthma.
RESULTS
Box 1 shows that the overall prevalence of asthma in this region
was 13.8%. A slightly higher prevalence was found in those 55
years or older (14.7%) compared with those under 55 years of age
(13.6%). More than a third of the 55 years and older group had
undiagnosed asthma, with almost 50% of older men having
significant acute bronchodilator reversibility without a previous
diagnosis of asthma or chronic obstructive pulmonary disease
(COPD). Box 1 also shows that lung function results (forced
expiratory volume in 1 second [FEV1]), pre- and post-bronchodi-
lator, were better in the older undiagnosed group than in the
diagnosed group, and that women had better lung function results
than men.
The respondents’ answers to questions about health service
use in the previous 12 months showed that both the diagnosed
and undiagnosed asthma groups visited their general practi-
tioner a mean number of 8.5 times, but the diagnosed group had
a slightly higher mean number of hospital emergency visits (1.9)
compared with the undiagnosed group (1.4). This difference
was not statistically significant.
Box 2 shows how the diagnosed and undiagnosed groups
compare on other health and demographic variables. For every
variable the proportions for the undiagnosed group are lower;
however, the only statistically significant variable is that of
“current or ex-smoker”, with a higher proportion of current and
ex-smokers in the diagnosed group.
The score for the physical and mental components summary
of the quality-of-life questionnaire was significantly lower for
both groups compared with that for the general north-west
Adelaide population. The score for the diagnosed group was also
significantly lower than that for the undiagnosed group
(P < 0.01) (Box 3).
Ten per cent of the undiagnosed group were categorised as
having moderate-to-severe asthma symptoms on the Selim index,7
compared with a significantly higher 38% in the diagnosed group
(χ2 = 22.6, 1 df, P < 0.0001).
DISCUSSION
What we need to know
In the subjects with undiagnosed asthma, lung function tests
before and after bronchodilator suggest that significant improve-
ments can be made in lung health. We need to know whether
early identification of this group is possible, and whether
medical care will improve health outcomes.
We also need to know whether appropriate strategies can be
developed to raise awareness that respiratory symptoms may be
due to asthma. It is important that the undiagnosed group
consulted their GP as often as the diagnosed group (ie, they were
known to the system but remained undiagnosed). Because of
this anomaly, we need to know whether subjects in the undia-
gnosed group have discussed these symptoms with their doctor.
If the answer is yes, we need to know whether GPs have been
unable to diagnose asthma. Perhaps the symptoms of the
undiagnosed subjects are less noticeable, either because they
have reduced perception of bronchoconstriction or have volun-
tarily restricted their activities so that they do not report
breathlessness.
For GPs, we need to know whether the potential for asthma in
older people with respiratory symptoms is clearly established on
their radar screen. In a recent focus group study in South
1 Asthma prevalence and lung function (forced expiratory volume in 1 second [FEV1]) before and after bronchodilator by 



















3.3 (2.4–4.2) 7.7 (6.4–8.0) 11.0 (10.4–12.6) 4.7 (3.6–5.8) 11.5 (9.8–13.2) 16.3 (14.4–18.2) 13.6 (12.3–14.9) 
Pre* FEV1 
% predicted
88.7 88.7 88.7 93.3 94.3 94.2
Post* FEV1 
% predicted
101.1 93.7 96.0 104.7 100.0 101.4




7.0 (4.9–7.1) 8.0 (5.7–10.3) 15.2 (13.2–17.2) 4.8 (3.2–6.4) 9.7 (7.7–11.3) 14.6 (12.7–16.9) 14.7 (12.7–16.7)
Pre* FEV1 
% predicted
79.0 73.3 75.9 83.4 84.8 84.3
Post* FEV1 
% predicted
91.2 78.2 84.2 96.9 90.2 92.4
* FEV1 was measured “pre” and “post” administration of 400μg of a short-acting bronchodilator (salbutamol) administered via a metered-dose inhaler and large volume spacer. MJA • Volume 183 Number 1 • 4 July 2005 S21
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asthma, considerable surprise was expressed that up to 50% of
elderly people with asthma could be undiagnosed. GPs reported
that knowing this would increase the vigilance of the profession
towards the target group.
We also need to know why some GPs do not use spirometry in
the diagnosis and management of airway obstruction. Is this a
time and cost problem, a skill problem or are there additional
factors that complicate innovation? It has been pointed out that
spirometry is underutilised in general practice and may be a
factor in underdiagnosis.11
What we need to do
We need to conduct further population studies to identify
whether older people with undiagnosed asthma have noticed
their symptoms, recognised them as asthma, and reported them
to their GP.
The method used to diagnose asthma in older people is often
a therapeutic trial, but no standardised approach has been
documented for such trials of therapy. To assess the potential
benefits of treatment in undiagnosed asthma, a representative
population group needs to be recruited to a trial of asthma
treatment to assess, quantify and cost the benefits, and produce
a standardised approach to this method of diagnosing asthma. A
study over time would also assess the potential to improve
health outcomes.
We need to analyse the issues associated with spirometry in
general practice focus groups to identify the reasons some GPs
do and some don’t conduct spirometry.
Focus groups could be the first stage in assessing GPs’
response to asthma symptoms in their older patients, where
asthma symptoms sit on their radar screen, and how the
differential diagnosis of respiratory complaints is conducted. It
is also important to know how GPs prioritise possible diagnostic
outcomes; for example, is heart disease the first priority and
asthma the last?
In summary, significant undiagnosed asthma occurs in older
people. Addressing this adequately will require a comprehensive
strategic plan to identify and deal with both the patient and
professional aspects of this problem.
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3 SF-36 quality-of-life scores — physical components 
summary and mental components summary — for 
subjects with diagnosed and undiagnosed asthma 

























2 Comparison of subjects with diagnosed and 
undiagnosed asthma by demographic and health-status 
variables
Variable Proportion Odds ratio P
Sex (diagnosed/undiagnosed)
Male 49.3% 1.0 P = 0.67
Female 50.0% 1.13
Income  $20 000
Diagnosed 51.4% 1.0 P = 0.73
Undiagnosed 49.0% 0.91
Place of birth
Australia 48.1% 1.0 P = 0.47
Elsewhere 47.5% 0.82
Education post secondary school
Diagnosed 39.3% 1.0 P = 0.70
Undiagnosed 36.6% 0.89
Smoker/ex-smoker




Undiagnosed 30.2% 0.83 P = 0.52
Exercise  150 min/week
Diagnosed 48.1 1.0 P = 0.47
Undiagnosed 47.5 0.82S22 MJA • Volume 183 Number 1 • 4 July 2005
